Risk of developing drug abuse in administration of a new hexaazaisowurtzitane derivative-based analgesic (experimental study)

The aim of the study was to assess the probability of developing withdrawal syndrome caused by discontinuation of 5-day administration of thiowurtzine with naloxone challenge test in the experiment.Materials and methods. The test sample of the analgesic “Thiowurtzine, capsule 120 mg” served as the s...

Full description

Bibliographic Details
Main Authors:	S. G. Krylova, T. N. Pove’teva, K. A. Lopatina, Yu. V. Nesterova, E. P. Zueva, O. G. Afanas’eva, P. V. Kulpin, E. A. Kiseleva, N. I. Suslov, D. A. Kulagina, S. V. Sysolyatin, V. V. Zhdanov
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2022-04-01
Series:	Бюллетень сибирской медицины
Subjects:	гексаазаизовюрцитан тиовюрцин анальгетическая активность синдром отмены физическая зависимость налоксон трамадол
Online Access:	https://bulletin.ssmu.ru/jour/article/view/4697

Internet

https://bulletin.ssmu.ru/jour/article/view/4697

Risk of developing drug abuse in administration of a new hexaazaisowurtzitane derivative-based analgesic (experimental study)

Internet

Similar Items